Loading...
Powered By
13 items
2025-07-11
GMO Research & AI, Inc., Q2 2025 Earnings Call, Aug 08, 2025
2025-06-27
GMO Research & AI, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025
2025-04-22
GMO Research & AI, Inc., Q1 2025 Earnings Call, May 14, 2025
2025-04-04
GMO Research & AI, Inc. expected to report First-Half, 2025 results on August 6, 2025. This event was calculated by S&P Global (Created on April 3, 2025).
2025-03-08
GMO Research & AI, Inc. announced that they will report Q1, 2025 results on May 13, 2025
2025-03-04
GMO Research, Inc. Common Stock will be deleted from OTC Equity effective March 03, 2025, due to Inactive Security.
2025-02-12
GMO Research & AI, Inc., Annual General Meeting, Mar 18, 2025.
2025-01-22
GMO Research & AI, Inc., 2024 Earnings Call, Feb 13, 2025
2024-12-14
GMO Research & AI, Inc. announced that they will report fiscal year 2024 results on Feb 12, 2025
2024-11-07
GMO Research & AI, Inc., ¥ 114.84, Cash Dividend, Dec-27-2024
2024-11-06
GMO Research & AI, Inc. expected to report Fiscal Year 2024 results on February 6, 2025. This event was calculated by S&P Global (Created on November 6, 2024).
2024-10-23
GMO Research & AI, Inc., Q3 2024 Earnings Call, Nov 06, 2024
2024-09-27
GMO Research & AI, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 5,729 | 4,982 | 5,025 | 4,973 | 5,001 | 5,051 | 5,117 | 5,230 |
Pretax Income Excl.Unusual Items | 248 | 30 | 248 | 181 | 297 | 366 | 435 | 347 |
Total Assets | 3,835 | 2,808 | 2,996 | 2,746 | 2,940 | 3,045 | 2,993 | 2,867 |
Total Liabilities | 1,583 | 982 | 885 | 821 | 947 | 1,069 | 947 | 883 |
Cash & Cash Equivalents | 1,629 | 836 | 688 | 763 | 958 | 876 | 884 | 1,058 |
Total Common Equity | 2,238 | 1,814 | 2,098 | 1,918 | 1,989 | 1,975 | 2,046 | 1,984 |
Book Value Per Share (BVPS) | 508.28 | 1,110.32 | 1,284.15 | 1,173.97 | 1,217.43 | 1,208.8 | 1,252.25 | 1,215.23 |
Net Change in Cash | 321 | -146 | 98 | 167 | ||||
Capital Expenditure | -1 | -1 | -1 |
On August 13, 2025, GMO Research & AI shared its financial results for the second quarter of 2025, with revenues of 1.85B yen and net income of 56M yen, representing a sharp 67.7% rise in revenues, with a transition from a loss per share in the same quarter last year to a profit per share in the current quarter.
and it trades at 51.5x times current year's earnings, which is higher than the sector average (P/E 9.1x).